Form 8-K - Current report:
SEC Accession No. 0001102624-17-000132
Filing Date
2017-03-08
Accepted
2017-03-08 12:43:17
Documents
4
Period of Report
2017-03-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 IMMUCELL CORPORATION 8-K immucell8k.htm 8-K 17391
2 EXHIBIT 99.1 exh99_1.htm EX-99.1 11400
3 EXHIBIT 99.2 exh99_2.htm EX-99.2 12393
4 EXHIBIT 99.3 exh99_3.htm EX-99.3 8564
  Complete submission text file 0001102624-17-000132.txt   50946
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 17674528
SIC: 2835 In Vitro & In Vivo Diagnostic Substances